Flavored, Oral Irinotecan VAL-413 (OrotecanĀ®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Valent Technologies, LLC
Valent Technologies, LLC
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)